16590-091 : Erythromycin 250 mg Oral Tablet

NDC:	16590-091
Labeler:	Stat Rx USA LLC
Product Type:	Human Prescription Drug
Drug Name:	Erythromycin
Dosage Form:	Oral Tablet, Film Coated
Application #:	ANDA061621
Rev. Date:	Jul 11, 1972

Appearance:

Markings:	EB
Shapes:	Oval
Colors:	Pink
Size (mm):	15
Segments: *	2
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

NDC Package Codes:

• 16590-091-30: 30 TABLET, FILM COATED IN 1 BOTTLE (16590‑091‑30)
• 16590-091-60: 60 TABLET, FILM COATED IN 1 BOTTLE (16590‑091‑60)
• 16590-091-90: 90 TABLET, FILM COATED IN 1 BOTTLE (16590‑091‑90)

Active Ingredients:

• Erythromycin

Inactive Ingredients:

• Colloidal Silicon Dioxide
• Croscarmellose Sodium
• Crospovidone
• Hydroxypropyl Cellulose
• Hypromelloses
• Magnesium Stearate
• Cellulose, Microcrystalline
• Povidone
• Polyethylene Glycol
• Propylene Glycol
• Sodium Citrate
• Sodium Hydroxide
• Sorbic Acid
• Sorbitan Monooleate
• Titanium Dioxide

Pharmaceutical Classes:

• Decreased Sebaceous Gland Activity [PE]
• Macrolide [EPC]
• Macrolide Antimicrobial [EPC]
• Macrolides [Chemical/Ingredient]

Related Products:

• 16590-088 Erythromycin 250 mg Delayed Release Capsule by Stat Rx USA
• 16590-090 Erythromycin 5 mg/g Ophthalmic Ointment by Stat Rx USA
• 0051-3389 Erythromycin 500 mg Oral Tablet by Abbvie Inc.
• 0051-6227 Erythromycin 500 mg Oral Tablet, Film Coated by Abbvie Inc.
• 0051-6290 Erythromycin 333 mg Oral Tablet by Abbvie Inc.
• 0051-6301 Erythromycin 250 mg Oral Capsule, Delayed Release by Abbvie Inc.
• 0051-6320 Erythromycin 333 mg Oral Tablet, Delayed Release by Abbvie Inc.
• 0051-6321 Erythromycin 500 mg Oral Tablet, Delayed Release by Abbvie Inc.
• 0051-6326 Erythromycin 250 mg Oral Tablet, Film Coated by Abbvie Inc.
• 0093-5571 Erythromycin 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
• 0093-5572 Erythromycin 500 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
• 0168-0215 Erythromycin 20 mg/ml Topical Solution by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
• 0168-0216 Erythromycin 20 mg/g Topical Gel by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
• 0179-0117 Erythromycin 250 mg Delayed Release Capsule by Kaiser Foundation Hospitals
• 0378-8212 Erythromycin 20 mg/g Topical Gel by Mylan Pharmaceuticals Inc.
• 0404-7191 Erythromycin 5 mg/g Ophthalmic Ointment by Henry Schein Inc.
• 0574-4024 Erythromycin 5 mg/g Ophthalmic Ointment by Paddock Laboratories, LLC
• 13668-586 Erythromycin 250 mg Oral Tablet, Delayed Release by Torrent Pharmaceuticals Limited
• 13668-588 Erythromycin 500 mg Oral Tablet, Delayed Release by Torrent Pharmaceuticals Limited
• 13668-606 Erythromycin 250 mg Oral Tablet, Coated by Torrent Pharmaceuticals Limited
• More related products ...

NDC QR Code

Related Discussions: